32 results on '"Boyle, F."'
Search Results
2. P263 Patients’ perspectives on treatments for HR+/HER2– early breast cancer: developing a quantitative patient preference survey
3. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
4. 91MO Randomized trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy to downstage ER+ve breast cancer: Breast Cancer Trials Group ANZ 1401 ELIMINATE trial
5. 59MO Adjuvant abemaciclib combined with endocrine therapy (ET): Efficacy results in monarchE cohort 1
6. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
7. Patients’ quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer
8. Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study
9. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
10. Consistent evidenced based information for women about fetal movements is important
11. 2MO Abemaciclib in high risk early breast cancer
12. 1886P Quantifying quality of informed consent (IC) in patients enrolled in phase I (ph I) oncology clinical trials with a validated instrument (QuIC Parts A, B) in a large United Kingdom phase I trials unit
13. LBA5_PR Abemaciclib in high risk early breast cancer
14. 275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)
15. Weaning practices in phenylketonuria vary between health professionals in Europe.
16. Weaning practices in phenylketonuria vary between health professionals in Europe
17. Early feeding practices in infants with phenylketonuria across Europe
18. Early feeding practices in infants with phenylketonuria across Europe
19. Early feeding practices in infants with phenylketonuria across Europe
20. Translating research into practice: The healthy living after cancer partnership project
21. Disease-Free Survival (Dfs) in the Lapatinib Alone Arm and Expanded Results of the Phase III Altto Trial (Big 2-06; Ncctg (Alliance) N063D) in the Adjuvant Treatment of Her2-Positive Early Breast Cancer (Ebc)
22. Neoadjuvant chemotherapy with sequential anthracycline–docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
23. Post-cancer fatigue is not associated with immune activation or altered cytokine production
24. Health-Related Quality of Life and Congenital Heart Disease in Australia
25. Dissemination of extended-spectrum β-lactamase-producing Escherichia coli at home: a potential occupational hazard for healthcare workers?
26. Communication about high-cost drugs in oncology—the patient view
27. A synthesis of (aR,7S)-(−)-N-acetylcolchinol and its conjugate with a cyclic RGD peptide
28. Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: Synthesis and structure–activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors
29. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
30. Seeking informed consent to cancer clinical trials
31. Paradoxical activation of Raf by a novel Raf inhibitor
32. Carboxylic acid bioisosteres of γ-linked dipeptide analogues of the folate-based thymidylate synthase (TS) inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.